Director/PDMR Shareholding

RNS Number : 2567L

GlaxoSmithKline PLC

02 July 2014

 



 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.

On 30 June 2014, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £15.67 per Ordinary Share, and notional ADSs at a price of $53.64 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2014 to 30 June 2014:

Non Executive Director	Ordinary Shares	American Depositary Shares (ADSs)
Sir Christopher Gent	3,988.513
Professor Sir Roy Anderson	578.334
Dr Stephanie Burns		433.930
Stacey Cartwright	458.679
Lynn Elsenhans		577.315
Judy Lewent		367.897
Sir Deryck Maughan		1,094.258
Dr Daniel Podolsky		820.694
Tom de Swaan	538.449
Jing Ulrich		273.565
Hans Wijers	458.679

The Company and the Non-Executive Directors were informed of these allocations on 1 July 2014.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

2 July 2014

 

END

 

 

RDSZLLFBZDFFBBB